🇺🇸ChronoScale (CHRN) classified its legacy exoskeleton business as held for sale, targeting fiscal 2027 divestiture to focus on GPU cloud.

ChronoScale Holdings Corp. reported that its board concluded on May 29, 2026, that the Legacy Ekso business met the accounting criteria to be classified as held for sale. The board committed to a divestiture plan intended to leave ChronoScale focused solely on its cloud business.

Legacy Ekso designs, develops, and markets robotic exoskeletons and related services for rehabilitation, personal mobility, and industrial applications. Most of that unit’s sales have come from enterprise healthcare products used for neurological rehabilitation in clinical settings.

ChronoScale expects to complete the divestiture during fiscal 2027, but the filing does not report a completed sale or identify a buyer. Its cloud operation currently supplies GPU computing for artificial intelligence, machine learning, rendering, and other high-performance computing workloads from third-party colocation facilities.

Management also described a planned four-layer cloud platform spanning infrastructure, compute, AI-platform capabilities, and implementation services. The filing explicitly says the deployment and expansion of these layers are forward-looking and were not reflected in operating results for the fiscal year ended May 31, 2026.